If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Proof of Concept Programme

11 Dec 2007 11:18

Imperial Innovations Group plc11 December 2007 Imperial Innovations Group plc ("Imperial Innovations") Proof of Concept programme Imperial Innovations Group plc (AIM: IVO) today announces the creation of a newUS$1 million Proof of Concept ("PoC") programme which has been funded byShapoorji Pallonji & Company Limited ("SPCL") a diversified conglomerateincluding the oldest construction company based in India. The objective of the PoC programme is to validate and accelerate the developmentof emerging technologies at Imperial College London for spin-out opportunities.Imperial Innovations will manage the programme including the recommendation,selection, and commercial assessment of the projects. The company isparticularly interested in developing technologies with SPCL which may lead tomarket applications and follow-on joint development opportunities in India. The PoC programme will fund three to five technologies of twelve to eighteenmonths' duration over the next two years and will give priority to applicationsin the built environment, whether renewable energy or energy-efficiencyinnovations. The creation of the PoC programme with SPCL builds on Imperial Innovations'ongoing activities in India which is regarded as one of the most importanttechnology markets for the future, including the recent formation of i2india,the technology commercialisation company based in India. Susan Searle, CEO of Imperial Innovations said: "The launch of the Shapoorji Proof of Concept programme will help us qualifyinventions in our intellectual property portfolio for more focused spin-outopportunities. Pre-commercial funding is very difficult to obtain forearly-stage technologies therefore we are extremely grateful for the fundingSPCL has provided. We are also encouraged that influential companies such asSPCL turn to us to access next generation technologies." Mr. Pallonji Mistry, Chairman of Shapoorji Pallonji & Co. Ltd., Mumbai said: "We look forward to a mutually rewarding and long term relationship withImperial Innovations through promoting development projects in selected areas." -Ends- For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 M:CommunicationsPatrick d'Ancona / Eleanor Williamson +44 (0)20 7153 1539 JPMorgan Cazenove (NOMAD to Imperial Innovations)Steve Baldwin +44(0)20 7588 2828 Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £25 million at an offer price of 365p and £1 million by meansof a public offer. In November 2007, the company raised a further £30 million bymeans of a placing of new ordinary shares with investors. The company's integrated approach encompasses the identification of ideas,protection of intellectual property, development and licensing of technology andformation, incubation and investment in technology businesses. A wide range oftechnologies are commercialised within the areas of healthcare, energy,environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in74 technology businesses and is managing 133 commercial agreements as of 31 July2007. Imperial Innovations also commercialises technologies originating fromoutside Imperial College through incubation contracts with the Carbon Trust andWRAP and has commercialisation contracts with a number of multinationalcorporations including BAE Systems. www.imperialinnovations.co.uk About Shapoorji Pallonji & Company Ltd Shapoorji Pallonji & Company Ltd is a diversified conglomerate with businessinterests in the construction, finance, biotechnology, and energy sectors. Thecompany started 140 years ago in Mumbai as a construction company. ShapoorjiPallonji has grown from its origins as India's oldest construction company andhas developed an international reputation in delivering complex projectsincluding factories, nuclear research establishments, nuclear waste handling,scientific and research establishments, stadia and auditoria, airports, hotels,hospitals, giant skyscrapers, housing complexes, townships, water treatmentplants, roads, expressways, power plants and biotech facilities. It is thelargest private shareholder (18.5%) of TATA SONS Ltd, the Holding Company of theTATA Group. The annual turnover of the TATA Group is over US$15 billion. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Apr 200912:06 pmPRNHolding(s) in Company
16th Apr 20097:00 amPRNNotice of Half Year Results
8th Apr 20096:21 pmPRNCompletion of Investment
2nd Apr 200910:45 amPRNClarification re. Investment in Portfolio Company
2nd Apr 20097:00 amPRNInvestment in Portfolio Company
24th Mar 20097:00 amRNSPortfolio Company Nexeon Announces New CEO
20th Feb 20097:00 amRNSSeed Funding in Three New Companies
11th Feb 20097:00 amRNSInvestment in Nexeon Ltd
4th Feb 20096:24 pmPRNHolding(s) in Company
29th Jan 20097:00 amRNSNew Portfolio Company Formation
23rd Jan 200910:49 amRNSNovacem wins rushlight award
20th Jan 20097:00 amRNSHolding(s) in Company
20th Jan 20097:00 amPRNTransfer of shares to Imperial College
7th Jan 20094:18 pmPRNHolding in Company
18th Dec 200812:27 pmPRNPortfolio Company Trade Sale
15th Dec 20083:20 pmPRNResult of AGM
17th Nov 20081:20 pmPRNNotice of AGM
14th Oct 20087:00 amPRNFinal Results
17th Sep 20089:30 amRNSSenior Appointments
11th Sep 20081:27 pmPRNPortfolio Company's Clinical Study Results
15th Aug 20087:00 amRNSPortfolio Companies Receive I
14th Aug 20084:35 pmPRNFormation of subsidiary authorised by FSA
10th Jul 20087:00 amPRNAppointment of non-executive director
2nd Jul 20087:00 amRNSAnnouncement re Recyclatech
23rd Jun 20087:00 amPRNInvestment in OSspray Limited
30th May 20089:00 amRNSInvestment in Evince
30th Apr 20087:00 amPRNHalf-yearly Report
22nd Apr 20083:28 pmPRNNotice of Results
14th Apr 20087:01 amRNSInvestment in Spiral Gateway
13th Mar 200811:53 amRNSTherapeutics portfolio update
21st Feb 20082:35 pmPRNDirectorate Change
20th Feb 200810:51 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amPRNInvestment in Circassia
21st Jan 200812:26 pmRNSi2india agreement with CCI
14th Jan 200810:30 amRNSBiosciences Deals
12th Dec 20073:04 pmRNSResult of AGM
11th Dec 200711:18 amRNSProof of Concept Programme
29th Nov 20074:00 pmRNSHolding(s) in Company
29th Nov 20073:59 pmRNSHolding(s) in Company
27th Nov 20072:04 pmRNSHolding(s) in Company
22nd Nov 20072:53 pmRNSTotal Voting Rights
22nd Nov 20078:00 amRNSFunding raised for i2india
22nd Nov 20078:00 amRNSAdmission of Shares on AIM
21st Nov 200712:11 pmRNSResult of EGM
14th Nov 200711:25 amRNSHolding(s) in Company
9th Nov 20073:56 pmPRNAnnual Report and Accounts
9th Nov 20079:00 amRNSEPS Licensing Deal
8th Nov 200711:55 amRNSHolding(s) in Company
30th Oct 20072:19 pmPRNCirc re GBP30m Placing
26th Oct 20071:35 pmPRNGBP30m placing successful

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.